NeuroRx

Research Services • Montreal, Quebec, Canada • 51-100 Employees

Company overview

Headquarters	3575 Avenue du Parc, Suite #5322, Montreal, Quebec H2X 3P9, CA
Phone number	+15149063909
Website	neurorx.com
NAICS	5417
SIC	873
Employees	51-100
Socials

Key Contacts at NeuroRx

Gokhan Calislar

Director, Training & Continuous Company Improvement

Alex Vartani

Associate Director Web-Based Applications

Simon Francis

Director Image Processing

Liane Chan

Director Of Project Management

Sukhjinder K. Narula

Director, Web-Based Applications

Ye Gu

Associate Director - Image Acquisition & Technical Support

NeuroRx Email Formats

NeuroRx uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@neurorx.com), used 85% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@neurorx.com	90%
{first name}	john@neurorx.com	10%

About NeuroRx

NeuroRx is dedicated to working with the pharmaceutical industry to facilitate clinical trials of new drugs for multiple sclerosis (MS) and other neurological diseases. NeuroRx provides professional management of all MRI-related study activities and promptly delivers precise MRI outcome measurements that are performed in a regulatory compliant environment. We are specialized in logistics of scan handling and tracking and can provide this service exclusively, if needed. NeuroRx uses advanced image analysis techniques to provide precise outcome data that maximize study power. Images are corrected for inhomogeneity and co-registered for perfect re-alignment and increased precision. Analyses are conducted in 3D, rather than on slices, so that information can be properly related to structures that span multiple slices. Customized automatic segmentation techniques are combined with expert supervision to maximize the precision of outcome measures related to both lesional and non-lesional pathology, as well as brain volume changes (atrophy).

NeuroRx revenue & valuation

Annual revenue	$7,500,000
Revenue per employee	$92,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$24,000,000
Total funding	No funding